Ep. 90 - PUSLECHECK: Insurance coverage of GLP-1s, Cyberstalking, and UnitedHealthcare's use of AI

This week on the FLATLINING Podcast from Fulcrum Strategies, Matthew Handley and CEO Ron Howrigon discuss several healthcare-related news items and how they affect patients and providers. They discuss for-profit HMO’s being banned from participating in Minnesota Medicaid products.  They also discuss the economic impact and future of insurance coverage for GLP-1 weight loss drugs such as Wegovy and Zepbound.  Also on the program: UnitedHealthcare has announced they will increase their usage of artificial intelligence.  Plus: a former AstraZeneca executive is charged with cyber stalking after he sent threatening messages to leadership at CVS Health and Aetna.--Articles mentioned in this program:For-profit HMOs will, again, be blocked from Minnesota's Medicaid program - Minneapolis Star Tribune Weight loss drug coverage gets more complicated - Becker's Payer IssuesReal-World Trends in GLP-1 Treatment Persistence and Prescribing for Weight Management - BlueCross BlueShieldUnitedHealth testing 500 AI use cases - Becker's Hospital ReviewPatient’s Dark Fantasy About Aetna Lands Him in Jail - The Daily Beast--Listen to the FLATLINING Podcast from Fulcrum Strategies wherever you listen to podcasts and have every episode delivered to your email by subscribing at www.FLATLINING.net.Follow Matthew on X and LinkedIn.Follow Ron on LinkedIn.Fulcrum Strategies is a healthcare consulting firm specializing in payer contract negotiation and strategic planning for physician practices.  Our firm has helped over 5,000 physicians in groups of all sizes and specialties across the country to significantly improve their contract language and reimbursement rates, strategically plan for the future, and achieve business success.  Learn more at FSDOC.com. This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.flatlining.net